BTIG’s Jonathan Krinsky is bullish on AppLovin Corporation ( NASDAQ: APP ), Flutter Entertainment ( NYSE: FLUT ), DraftKings ...

BTIG raised the firm’s price target on Okta (OKTA) to $110 from $98 and keeps a Buy rating on the shares. Against a difficult earnings season ...

BTIG lowered the firm’s price target on Alexandria Real Estate (ARE) to $144 from $186 and keeps a Buy rating on the shares. The firm notes ...

BTIG raised the firm’s price target on Upwork (UPWK) to $18 from $16 and keeps a Buy rating on the shares as part of a ...

BTIG raised the firm’s price target on SuRo Capital (SSSS) to $6.50 from $6 and keeps a Buy rating on the shares as part of a ...

Fintel reports that on December 2, 2024, BTIG initiated coverage of BrightView Holdings (NYSE:BV) with a Buy recommendation.

Fintel reports that on December 2, 2024, BTIG downgraded their outlook for AnaptysBio (NasdaqGS:ANAB) from Buy to Neutral.

Investing.com -- According to a note from BTIG on Monday, the tech sector's ongoing weakness is raising concerns as markets ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 ...

Outlook Therapeutics (NASDAQ:OTLK – Free Report) had its target price reduced by BTIG Research from $50.00 to $9.00 in a ...

AnaptysBio (NASDAQ:ANAB – Get Free Report) was downgraded by investment analysts at BTIG Research from a “buy” rating to a “neutral” rating in a research report issued on Monday, MarketBeat reports.

Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...